Immunotoxicology.
D000818:Animals; D001194:Asbestos / Q000009:adverse effects; D004342:Drug Hypersensitivity; D006801:Humans; D007108:Immune Tolerance / Q000187:drug effects; D007111:Immunity, Cellular / Q000187:drug effects; D007121:Immunocompetence / Q000187:drug effects*; D007153:Immunologic Deficiency Syndromes / Q000276:immunology; D007166:Immunosuppressive Agents / Q000009:adverse effects; D008175:Lung Neoplasms / Q000139:chemically induced; D051379:Mice; D009369:Neoplasms / Q000139:chemically induced / Q000276:immunology; D011075:Polybrominated Biphenyls / Q000009:adverse effects; D000072317:Polychlorinated Dibenzodioxins / Q000009:adverse effects; D051381:Rats; D013601:T-Lymphocytes / Q000276:immunology
D007166:Immunosuppressive Agents; D011075:Polybrominated Biphenyls; D000072317:Polychlorinated Dibenzodioxins; D001194:Asbestos